Organ Transplant Patient Dies After Receiving Covid Infected Lungs
A woman died of COVID-19 after receiving an infected double-lung transplant.
Transplantation
Kidney Transplant Outcomes Similar With Hep C+ Donors
At 1 year after transplant, kidney allograft function, rejection rates similar regardless of donor hepatitis C status.
Despite Hepatitis C Virus Status, Many Positive Liver Allograft Donors Were Healthier and Younger
Increased utilization of HCV-positive liver allografts for LT is seen as one of the ways to counter national organ shortages, so researchers set out to better characterize the allografts that come from HCV-positive donors from specific regions.
Patient Access to Liver Transplantation Unaffected by COVID-19 Pandemic
Investigators evaluated the COVID-19 pandemic’s impact on patient access to liver transplantation.
Antifungal Prophylaxis in Hematological Disease or Hematopoietic Stem Cell Transplantation
Investigators summarized the evidence on the efficacy and adverse effects of antifungal agents in patients with hematological disease or undergoing hematopoietic stem cell transplantation.
Antifungal Prophylaxis Reduces Mortality in Lung Transplantation
Lung transplant recipients who were given antifungal medications prophylactically to prevent invasive fungal infections had lower rates of mortality.
COVID-19 Diagnosis Increases Hospitalization Risk in People With Liver Transplant
Although hospitalization risk was higher, mortality, thrombosis, and ICU admission risks were the same in patients with and without liver transplants.
Study Finds Vancomycin Increased Risk for Cytomegalovirus Reactivation After Hematopoietic Cell Transplant
A retrospective study of CMV-seropositive adults receiving allogeneic HCT and CMV-seronegative HLA-matched sibling donors found that vancomycin exposure before HCT increased the risk for CMV reactivation.
Characteristics and Outcomes of Heart Transplant Recipients With COVID-19
As heart transplant recipients may be at increased risk for infection with COVID-19, investigators sought to identify characteristics, treatment, and outcomes of this patient population.
mRECIST Inclusion Improves Metroticket 2.0 Criteria Prediction for Liver Transplantation
A more accurate prediction for assessing the eligibility of candidates for liver transplantation who received neoadjuvant therapies was shown when mRECIST radiologic response was included within the Metroticket 2.0 framework.
- Loading...
Loading...
Next post in Diagnostics
Loading... 
Loading...